Showing results (291-300 of 319) with videos related to
Sort By:
Pageof 32
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2026
Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapyMatthew A Powell, Sharad Ghamande, Lars C Hanker, et al.American Journal of Obstetrics and Gynecology|August 30, 2021
Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment StudyGloria Salvo, Pedro T Ramirez, Mario M Leitao, et al.American Journal of Obstetrics and Gynecology|June 19, 2023
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative studyNicolò Bizzarri, Denis Querleu, Lukáš Dostálek, et al.Nature Communications|April 17, 2026
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinomaTereza Lanickova, Artemis Angelidou, Michal Hensler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2023
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 StudyIgnace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill, et al.Gynecologic Oncology|April 18, 2026
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 studyEls Van Nieuwenhuysen, Ignace Vergote, Leslie M Randall, et al.The New England Journal of Medicine|March 27, 2023
Dostarlimab for Primary Advanced or Recurrent Endometrial CancerMansoor R Mirza, Dana M Chase, Brian M Slomovitz, et al.European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancerDavid Cibula, Lukáš Dostálek, Jiri Jarkovsky, et al.European Journal of Cancer (Oxford, England : 1990)|September 13, 2024
Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative studyNicolò Bizzarri, Denis Querleu, Pedro T Ramirez, et al.Obstetrics and Gynecology|January 26, 2023
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical HysterectomyNicolò Bizzarri, Lukáš Dostálek, Luc R C W van Lonkhuijzen, et al.Pageof 32